Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational StudyAlessandra Bettiol, Florenzo Iannone, Maria Letizia Urban et al.|Arthritis & Rheumatology|2021Cited by 165
Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real‐Life SettingMariele Gatto, Roberto Gerli, Micaela Fredi et al.|Arthritis & Rheumatology|2020Cited by 113